Since we have shown previously that daily oral application of the small molecule DHODH-inhibitor PP-001 is highly effective in suppressing experimental autoimmune uveitis in two different rat models (relapsing-remitting and chronic disease with neovascularizations) [2], we decided to investigate its therapeutic effect after intraocular injection. The gene discussed is DHODH; the disease is autoimmune uveitis.